Skip to main content

Discover cutting-edge genomics insights and expertise

Genomic and pathogen analysis is crucial for the future of medicine and healthcare, especially with concerns about infectious or deadly virus variants rising since the COVID-19 pandemic.

We offer rapid whole genome virus sequencing services using Oxford Nanopore Technologies, capable of sequencing up to 1,000 samples daily at our Nottingham facility.

Our suite of devices supports various OMICS research projects, partnering with clients to meet diverse needs across the whole spectrum of Genomic research:

  • Proteomics: our expertise and equipment can provide clients with a better understanding of the structure and function of organisms.​
  • Transcriptomics: we can help analyse how DNA is expressed as proteins and other molecules.​
  • Genomics: we help clients study the complete set of DNA or RNA of an organism.
  • Pharmacogenomics: the science of tailoring prescription drugs to suit a patient’s unique genomic profile, ensuring improved effectiveness of treatment and removing risk factors.​
  • Metabolomics: we have capabilities which enable large-scale study of small molecules – commonly known as metabolites – within cells, biofluids, tissues or organisms.​
  • Lipid omics: we have equipment that studies reaction pathways involved in lipid metabolism within biological systems.​
  • Epigenomics: our researchers chart the locations and understand the functions of all the chemical tags that mark the genome.

Expertise and services

Discover the experts and facilities behind our genomics research offer.

Dr Adam Varney

Dr Adam Varney

Biosciences Research Fellow

Dr Varney studied a PhD in Microbiology at Nottingham Trent University before taking on the role of Research Fellow at MTIF.

Oliver Megram

Oliver Megram

Analytical Spectroscopy Researcher

With a wealth of experience in optimizing and developing laboratory workflows in both high-throughput and small-scale labs, Oliver’s current research explores different metabolic diseases and biofluids using bNMR spectrometers for future detection, diagnostics, and monitoring purposes.

View our Genomics suite

The Medical Technologies Innovation Facility boasts a suite of state-of-the-art Oxford Nanopore instruments, capable of both high-throughput and long whole-genome sequencing runs. These include, but are not limited to:

  • GridION: On-demand benchtop sequencing, running up to 5 MinION/Flongle flow cells at any one time. Its system capacity consists of a maximum of 250 GB.
  • MinION: Portable DNA/RNA sequencing that has a system capacity translated into bases per 72 hour run per flow cell (at 450 bps), of 60 Gb. The MinION device has capabilities of 512 channels and data delivered in real time, which can be run for as long or as little as required.

Explore more

Technician working with NMR Spectrometer

Spectroscopy Analysis

Our cutting-edge technology and unparalleled expertise deliver precise and reliable results for effective spectroscopy analysis.